Coronary artery bypass grafting: Part 1--the evolution over the first 50 years

Stuart J Head1, Teresa M Kieser, Volkmar Falk

  • 1Department of cardiothoracic surgery, Erasmus University Medical Center, Rotterdam, The Netherlands.

European Heart Journal
|October 3, 2013
PubMed

Insights

Coronary artery bypass grafting (CABG) has evolved from experimental procedures to a safe and efficient surgical treatment for angina pectoris over nearly 50 years. This review summarizes its historical development and current clinical outcomes.

Area of Science:

  • Cardiovascular Surgery
  • Medical History

Background:

  • Surgical interventions for angina pectoris were first conceptualized in the late 19th century.
  • Coronary artery disease (CAD) research spurred decades of experimental cardiac surgery.
  • Coronary Artery Bypass Grafting (CABG) was introduced in 1964.

Purpose of the Study:

  • To review the historical progression of CABG.
  • To detail the evolution of CABG surgical techniques.
  • To discuss contemporary clinical outcomes of CABG.

Main Methods:

  • Historical recapitulation of experimental cardiac surgery.
  • Analysis of the evolution of CABG surgical techniques.
  • Review of CABG utilization data.
  • Discussion of current clinical outcome data.

Main Results:

  • CABG has transformed from experimental origins to a standard, safe, and efficient procedure.
  • Significant advancements in surgical techniques have occurred over decades.
  • Contemporary CABG procedures demonstrate favorable clinical outcomes.

Conclusions:

  • CABG represents a major advancement in treating angina pectoris.
  • The historical trajectory of CABG highlights continuous innovation in cardiac surgery.
  • Current outcomes confirm CABG as an effective treatment for coronary artery disease.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
319
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
822
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
196